For chemoresistance in ESCC, the highly overexpressed ALKBH5-induced lncRNA CASC8 activate the Bcl2/Caspase3 pathway to decrease the cisplatin sensitivity of ESCC and promote tumor development 91. This evidence concerns the gene CASC8 and esophageal squamous cell carcinoma.